0001628280-23-041703.txt : 20231215
0001628280-23-041703.hdr.sgml : 20231215
20231215182859
ACCESSION NUMBER: 0001628280-23-041703
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231214
FILED AS OF DATE: 20231215
DATE AS OF CHANGE: 20231215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nouri Alaleh
CENTRAL INDEX KEY: 0001599418
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40797
FILM NUMBER: 231491757
MAIL ADDRESS:
STREET 1: 1310 CHESAPEAKE TERRACE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp
CENTRAL INDEX KEY: 0001588978
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 260199180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 ISLAND DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-232-7200
MAIL ADDRESS:
STREET 1: 900 ISLAND DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
4
1
wk-form4_1702682929.xml
FORM 4
X0508
4
2023-12-14
0
0001588978
PROCEPT BioRobotics Corp
PRCT
0001599418
Nouri Alaleh
C/O PROCEPT BIOROBOTICS CORPORATION
150 BAYTECH DRIVE
SAN JOSE
CA
95134
0
1
0
0
EVP, CLO, CORP. SEC.
1
Common Stock
2023-12-14
4
M
0
3204
4.56
A
50137
D
Common Stock
2023-12-14
4
S
0
3204
42.9518
D
46933
D
Common Stock
2023-12-15
4
M
0
11796
4.56
A
58729
D
Common Stock
2023-12-15
4
S
0
11796
42.9674
D
46933
D
Stock Option (Right to Buy)
4.56
2023-12-14
4
M
0
3204
0
D
2029-12-12
Common Stock
3204
41493
D
Stock Option (Right to Buy)
4.56
2023-12-15
4
M
0
11796
0
D
2029-12-12
Common Stock
11796
29697
D
All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.95 to $42.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.95 to $43.025, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The Stock Option was granted on December 12, 2019 and vested over a four year period
/s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri
2023-12-15